Skip to main content
Premium Trial:

Request an Annual Quote

Innova Biosciences Inks China Distribution Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Innova Biosciences has tapped Genetimes Technology and NeoBioscience Technology Company to distribute its antibody labeling kits in China.

Based at the Babraham Institute in Cambridge, UK, Innova Biosciences offers the Lightning-Link kits for bioconjugation tasks to hospitals and research labs.

The company said that it received support and consultation from the UK Trade and Investment in forming the distribution partnerships.

Genetimes is based in Shanghai, and NeoBioscience Technology is based in Shenzhen.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.